Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 168

1.

[Vibrio cholerae non-O1/non-O139 otitis in metropolitan France].

Leroy AG, Lerailler F, Quilici ML, Bourdon S.

Med Mal Infect. 2019 Aug;49(5):359-361. doi: 10.1016/j.medmal.2019.03.003. Epub 2019 Mar 28. French. No abstract available.

PMID:
30928182
2.

Publisher Correction: Genomic insights into the 2016-2017 cholera epidemic in Yemen.

Weill FX, Domman D, Njamkepo E, Almesbahi AA, Naji M, Nasher SS, Rakesh A, Assiri AM, Sharma NC, Kariuki S, Pourshafie MR, Rauzier J, Abubakar A, Carter JY, Wamala JF, Seguin C, Bouchier C, Malliavin T, Bakhshi B, Abulmaali HHN, Kumar D, Njoroge SM, Malik MR, Kiiru J, Luquero FJ, Azman AS, Ramamurthy T, Thomson NR, Quilici ML.

Nature. 2019 Feb;566(7745):E14. doi: 10.1038/s41586-019-0966-0.

PMID:
30755740
3.

Genomic insights into the 2016-2017 cholera epidemic in Yemen.

Weill FX, Domman D, Njamkepo E, Almesbahi AA, Naji M, Nasher SS, Rakesh A, Assiri AM, Sharma NC, Kariuki S, Pourshafie MR, Rauzier J, Abubakar A, Carter JY, Wamala JF, Seguin C, Bouchier C, Malliavin T, Bakhshi B, Abulmaali HHN, Kumar D, Njoroge SM, Malik MR, Kiiru J, Luquero FJ, Azman AS, Ramamurthy T, Thomson NR, Quilici ML.

Nature. 2019 Jan;565(7738):230-233. doi: 10.1038/s41586-018-0818-3. Epub 2019 Jan 2. Erratum in: Nature. 2019 Feb;566(7745):E14.

4.

Evaluation of the SD bioline cholera rapid diagnostic test during the 2016 cholera outbreak in Lusaka, Zambia.

Mwaba J, Ferreras E, Chizema-Kawesa E, Mwimbe D, Tafirenyika F, Rauzier J, Blake A, Rakesh A, Poncin M, Stoitsova S, Kwenda G, Azman AS, Chewe O, Serafini M, Lukwesa-Musyani C, Cohuet S, Quilici ML, Luquero FJ, Page AL.

Trop Med Int Health. 2018 Aug;23(8):834-840. doi: 10.1111/tmi.13084. Epub 2018 Jun 29.

5.

Cholera epidemic in Yemen, 2016-18: an analysis of surveillance data.

Camacho A, Bouhenia M, Alyusfi R, Alkohlani A, Naji MAM, de Radiguès X, Abubakar AM, Almoalmi A, Seguin C, Sagrado MJ, Poncin M, McRae M, Musoke M, Rakesh A, Porten K, Haskew C, Atkins KE, Eggo RM, Azman AS, Broekhuijsen M, Saatcioglu MA, Pezzoli L, Quilici ML, Al-Mesbahy AR, Zagaria N, Luquero FJ.

Lancet Glob Health. 2018 Jun;6(6):e680-e690. doi: 10.1016/S2214-109X(18)30230-4. Epub 2018 May 3.

6.

Cholera Epidemic in South Sudan and Uganda and Need for International Collaboration in Cholera Control.

Abubakar A, Bwire G, Azman AS, Bouhenia M, Deng LL, Wamala JF, Rumunu J, Kagirita A, Rauzier J, Grout L, Martin S, Orach CG, Luquero FJ, Quilici ML.

Emerg Infect Dis. 2018 May;24(5):883-887. doi: 10.3201/eid2405.171651.

7.

Single-Dose Cholera Vaccine in Response to an Outbreak in Zambia.

Ferreras E, Chizema-Kawesha E, Blake A, Chewe O, Mwaba J, Zulu G, Poncin M, Rakesh A, Page AL, Stoitsova S, Voute C, Uzzeni F, Robert H, Serafini M, Matapo B, Eiros JM, Quilici ML, Pezzoli L, Azman AS, Cohuet S, Ciglenecki I, Malama K, Luquero FJ.

N Engl J Med. 2018 Feb 8;378(6):577-579. doi: 10.1056/NEJMc1711583. No abstract available.

8.

Cholera in Brest, France.

Pougnet L, Pougnet R, Voarino A, Sapin J, Drouillard I, Quilici ML, Désidéri-Vaillant C.

Ann Biol Clin (Paris). 2018 Jan 1;76(1):107-110. doi: 10.1684/abc.2017.1307.

PMID:
29313493
9.

Integrated view of Vibrio cholerae in the Americas.

Domman D, Quilici ML, Dorman MJ, Njamkepo E, Mutreja A, Mather AE, Delgado G, Morales-Espinosa R, Grimont PAD, Lizárraga-Partida ML, Bouchier C, Aanensen DM, Kuri-Morales P, Tarr CL, Dougan G, Parkhill J, Campos J, Cravioto A, Weill FX, Thomson NR.

Science. 2017 Nov 10;358(6364):789-793. doi: 10.1126/science.aao2136.

PMID:
29123068
10.

Genomic history of the seventh pandemic of cholera in Africa.

Weill FX, Domman D, Njamkepo E, Tarr C, Rauzier J, Fawal N, Keddy KH, Salje H, Moore S, Mukhopadhyay AK, Bercion R, Luquero FJ, Ngandjio A, Dosso M, Monakhova E, Garin B, Bouchier C, Pazzani C, Mutreja A, Grunow R, Sidikou F, Bonte L, Breurec S, Damian M, Njanpop-Lafourcade BM, Sapriel G, Page AL, Hamze M, Henkens M, Chowdhury G, Mengel M, Koeck JL, Fournier JM, Dougan G, Grimont PAD, Parkhill J, Holt KE, Piarroux R, Ramamurthy T, Quilici ML, Thomson NR.

Science. 2017 Nov 10;358(6364):785-789. doi: 10.1126/science.aad5901.

PMID:
29123067
11.

Cholera Rapid Test with Enrichment Step Has Diagnostic Performance Equivalent to Culture.

Ontweka LN, Deng LO, Rauzier J, Debes AK, Tadesse F, Parker LA, Wamala JF, Bior BK, Lasuba M, But AB, Grandesso F, Jamet C, Cohuet S, Ciglenecki I, Serafini M, Sack DA, Quilici ML, Azman AS, Luquero FJ, Page AL.

PLoS One. 2016 Dec 19;11(12):e0168257. doi: 10.1371/journal.pone.0168257. eCollection 2016.

12.

Effectiveness of one dose of oral cholera vaccine in response to an outbreak: a case-cohort study.

Azman AS, Parker LA, Rumunu J, Tadesse F, Grandesso F, Deng LL, Lino RL, Bior BK, Lasuba M, Page AL, Ontweka L, Llosa AE, Cohuet S, Pezzoli L, Sodjinou DV, Abubakar A, Debes AK, Mpairwe AM, Wamala JF, Jamet C, Lessler J, Sack DA, Quilici ML, Ciglenecki I, Luquero FJ.

Lancet Glob Health. 2016 Nov;4(11):e856-e863. doi: 10.1016/S2214-109X(16)30211-X.

13.

Risk Factors for Foot Amputation in Patients Hospitalized for Diabetic Foot Infection.

Quilici MT, Del Fiol Fde S, Vieira AE, Toledo MI.

J Diabetes Res. 2016;2016:8931508. doi: 10.1155/2016/8931508. Epub 2016 Feb 22.

14.

Baseline characteristics and risk factors for ulcer, amputation and severe neuropathy in diabetic foot at risk: the BRAZUPA study.

Parisi MC, Moura Neto A, Menezes FH, Gomes MB, Teixeira RM, de Oliveira JE, Pereira JR, Fonseca RM, Guedes LB, Costa E Forti A, de Oliveira AM, de Medeiros Nóbrega MB, Colares VN, Schmid H, Nienov OH, Nery M, Fernandes TD, Pedrosa HC, Schreiber de Oliveira Cda S, Ronsoni M, Rezende KF, Quilici MT, Vieira AE, de Macedo GM, Stuchi-Perez EG, Dinhane KG, Pace AE, de Freitas MC, Calsolari MR, Saad MJ.

Diabetol Metab Syndr. 2016 Mar 17;8:25. doi: 10.1186/s13098-016-0126-8. eCollection 2016.

15.

Non-O1, non-O139 Vibrio cholerae bacteraemia: case report and literature review.

Deshayes S, Daurel C, Cattoir V, Parienti JJ, Quilici ML, de La Blanchardière A.

Springerplus. 2015 Oct 5;4:575. doi: 10.1186/s40064-015-1346-3. eCollection 2015.

16.

Prevalence of Vibrio spp. in raw shrimps (Parapenaeus longirostris) and performance of a chromogenic medium for the isolation of Vibrio strains.

Kriem MR, Banni B, El Bouchtaoui H, Hamama A, El Marrakchi A, Chaouqy N, Robert-Pillot A, Quilici ML.

Lett Appl Microbiol. 2015 Sep;61(3):224-30. doi: 10.1111/lam.12455. Epub 2015 Jul 8.

17.

Occurrence of the three major Vibrio species pathogenic for human in seafood products consumed in France using real-time PCR.

Robert-Pillot A, Copin S, Himber C, Gay M, Quilici ML.

Int J Food Microbiol. 2014 Oct 17;189:75-81. doi: 10.1016/j.ijfoodmicro.2014.07.014. Epub 2014 Jul 18.

PMID:
25128747
18.

Use of Vibrio cholerae vaccine in an outbreak in Guinea.

Luquero FJ, Grout L, Ciglenecki I, Sakoba K, Traore B, Heile M, Diallo AA, Itama C, Page AL, Quilici ML, Mengel MA, Eiros JM, Serafini M, Legros D, Grais RF.

N Engl J Med. 2014 May 29;370(22):2111-20. doi: 10.1056/NEJMoa1312680.

19.

Use of a cholera rapid diagnostic test during a mass vaccination campaign in response to an epidemic in Guinea, 2012.

Martinez-Pino I, Luquero FJ, Sakoba K, Sylla S, Haile M, Grais RF, Ciglenecki I, Quilici ML, Page AL.

PLoS Negl Trop Dis. 2013 Aug 15;7(8):e2366. doi: 10.1371/journal.pntd.0002366. eCollection 2013.

20.

Risk of Vibrio transmission linked to the consumption of crustaceans in coastal towns of Côte d'Ivoire.

Traoré SG, Bonfoh B, Krabi R, Odermatt P, Utzinger J, Rose KN, Tanner M, Frey J, Quilici ML, Koussémon M.

J Food Prot. 2012 Jun;75(6):1004-11. doi: 10.4315/0362-028X.JFP-11-472.

21.

Evaluation of a rapid test for the diagnosis of cholera in the absence of a gold standard.

Page AL, Alberti KP, Mondonge V, Rauzier J, Quilici ML, Guerin PJ.

PLoS One. 2012;7(5):e37360. doi: 10.1371/journal.pone.0037360. Epub 2012 May 30.

22.

A cluster of acute diarrhea suspected to be cholera in French travelers in Haiti, December 2010.

Haus-Cheymol R, Theodose R, Quilici ML, Chevallier G, Liautaud B, Ktari F, Garcia J, de Laval F, Migliani R.

J Travel Med. 2012 May-Jun;19(3):189-91. doi: 10.1111/j.1708-8305.2012.00607.x.

23.

Evaluation of most-probable-number-PCR method with internal amplification control for the counting of total and pathogenic Vibrio parahaemolyticus in frozen shrimps.

Copin S, Robert-Pillot A, Malle P, Quilici ML, Gay M.

J Food Prot. 2012 Jan;75(1):150-3. doi: 10.4315/0362-028X.JFP-11-165.

PMID:
22221369
24.

Use of filter paper as a transport medium for laboratory diagnosis of cholera under field conditions.

Page AL, Alberti KP, Guénolé A, Mondongue V, Lonlas Mayele S, Guerin PJ, Quilici ML.

J Clin Microbiol. 2011 Aug;49(8):3021-3. doi: 10.1128/JCM.00514-11. Epub 2011 Jun 22.

25.

Fatal Vibrio vulnificus infection associated with eating raw oysters, New Caledonia.

Cazorla C, Guigon A, Noel M, Quilici ML, Lacassin F.

Emerg Infect Dis. 2011 Jan;17(1):136-7. doi: 10.3201/eid1701.100603. No abstract available.

26.

Vibrio cholerae O1 variant with reduced susceptibility to ciprofloxacin, Western Africa.

Quilici ML, Massenet D, Gake B, Bwalki B, Olson DM.

Emerg Infect Dis. 2010 Nov;16(11):1804-5. doi: 10.3201/eid1611.100568. No abstract available.

27.

Total and pathogenic Vibrio parahaemolyticus in shrimp: fast and reliable quantification by real-time PCR.

Robert-Pillot A, Copin S, Gay M, Malle P, Quilici ML.

Int J Food Microbiol. 2010 Oct 15;143(3):190-7. doi: 10.1016/j.ijfoodmicro.2010.08.016. Epub 2010 Aug 25.

PMID:
20843573
28.

Non-O1, non-O139 Vibrio cholerae bacteraemia in a cirrhotic patient.

Petsaris O, Nousbaum JB, Quilici ML, Le Coadou G, Payan C, Abalain ML.

J Med Microbiol. 2010 Oct;59(Pt 10):1260-2. doi: 10.1099/jmm.0.021014-0. Epub 2010 Jul 8.

PMID:
20616193
29.

Molecular analyses of Vibrio cholerae O1 clinical strains, including new nontoxigenic variants isolated in Mexico during the Cholera epidemic years between 1991 and 2000.

Lizárraga-Partida ML, Quilici ML.

J Clin Microbiol. 2009 May;47(5):1364-71. doi: 10.1128/JCM.00720-08. Epub 2009 Feb 11.

30.

Antimicrobial resistance and molecular characterization of Vibrio cholerae O1 during the 2004 and 2005 outbreak of cholera in Cameroon.

Ngandjio A, Tejiokem M, Wouafo M, Ndome I, Yonga M, Guenole A, Lemee L, Quilici ML, Fonkoua MC.

Foodborne Pathog Dis. 2009 Jan-Feb;6(1):49-56. doi: 10.1089/fpd.2008.0127.

PMID:
18991540
31.

A cluster of Vibrio cholerae O1 infections in French travelers to Rajasthan (India), May 2006.

Tarantola A, Vaucel J, Laviolle C, Quilici ML, Thiolet JM, Fournier JM; Incident Management Group.

J Travel Med. 2008 Jul-Aug;15(4):273-7. doi: 10.1111/j.1708-8305.2008.00210.x.

32.

Vibrio cholerae O1 strains with decreased susceptibility to fluoroquinolones in travellers returning from India (Rajasthan) to France, April 2007.

Tarantola A, Quilici ML; Laboratory Investigation Group.

Euro Surveill. 2007 May 3;12(5):E070503.2. No abstract available.

33.

Retrospective analysis of the cholera cases imported to France from 1973 to 2005.

Tarantola A, Ioos S, Rotureau B, Paquet C, Quilici ML, Fournier JM.

J Travel Med. 2007 Jul-Aug;14(4):209-14.

34.

[Cholera].

Fournier JM, Quilici ML.

Presse Med. 2007 Apr;36(4 Pt 2):727-39. Epub 2007 Mar 1. Review. French.

PMID:
17336031
35.

[Cases of imported cholera in France, summer 2005. A. Tarantola for the incident management teams].

Groupes de Gestion des Incidents, Ajzenman C, Bizet MC, Dufraisse MP, Falip E, Fournier JM, Etchegorry MG, Haeghebaert S, Isnard H, Le Loc'h H, Mansir T, Quilici ML, Raqbi F, Raud E, Roberto Y, Scanvic A, Senellier M, Sirot S, Tarantola A.

Med Mal Infect. 2006 Jun;36(6):346-8. Epub 2006 Jun 27. French.

PMID:
16806780
36.

Pandemic Vibrio parahaemolyticus O3:K6 spread, France.

Quilici ML, Robert-Pillot A, Picart J, Fournier JM.

Emerg Infect Dis. 2005 Jul;11(7):1148-9. No abstract available.

37.

Occurrence of the tdh and trh genes in Vibrio parahaemolyticus isolates from waters and raw shellfish collected in two French coastal areas and from seafood imported into France.

Robert-Pillot A, Guénolé A, Lesne J, Delesmont R, Fournier JM, Quilici ML.

Int J Food Microbiol. 2004 Mar 15;91(3):319-25.

PMID:
14984780
38.

[Vibrio vulnificus septicemia transmitted through a wound caused by a crustacea].

Renault PA, Vargas C, Tachet A, Tattevin P, Najman A, Quilici ML, Fournier JM.

Presse Med. 2003 Jun 21;32(22):1028-30. French.

PMID:
12876519
39.

Septicaemia and liver abscesses secondary to non-O1/non-O139 Vibrio cholerae colitis.

Farmachidi JP, Sobesky R, Boussougant Y, Quilici ML, Coffin B.

Eur J Gastroenterol Hepatol. 2003 Jun;15(6):699-700. No abstract available.

PMID:
12840683
40.

Improved specific detection of Vibrio cholerae in environmental water samples by culture on selective medium and colony hybridization assay with an oligonucleotide probe.

Robert-Pillot A, Baron S, Lesne J, Fournier JM, Quilici ML.

FEMS Microbiol Ecol. 2002 Apr 1;40(1):39-46. doi: 10.1111/j.1574-6941.2002.tb00934.x.

41.

Nontoxigenic vibrio Cholerae O1 bacteremia: case report and review.

Ninin E, Caroff N, El Kouri D, Espaze E, Richet H, Quilici ML, Fournier JM.

Eur J Clin Microbiol Infect Dis. 2000 Jun;19(6):489-91. Review. No abstract available.

PMID:
10947231
42.

Cholera in Madagascar.

Duval P, Champetier de Ribes G, Ranjalahy J, Quilici ML, Fournier JM.

Lancet. 1999 Jun 12;353(9169):2068. No abstract available.

PMID:
10376637
43.

Emergence of cholera in the Central African Republic.

Germani Y, Quilici ML, Glaziou P, Mattera D, Morvan J, Fournier JM.

Eur J Clin Microbiol Infect Dis. 1998 Dec;17(12):888-90. No abstract available.

PMID:
10052560
44.

Ritodrine sulphation in the human liver and duodenal mucosa: interindividual variability.

Pacifici GM, Quilici MC, Giulianetti B, Spisni R, Nervi M, Giuliani L, Gomeni R.

Eur J Drug Metab Pharmacokinet. 1998 Jan-Mar;23(1):67-74.

PMID:
9625275
45.

Multilocus enzyme electrophoresis analysis of Candida albicans isolates from three intensive care units. An epidemiological study.

Arnavielhe S, Blancard A, Mallié M, Quilici M, Bastide JM.

Mycoses. 1997 Oct;40(5-6):159-67.

PMID:
9476482
46.

(-)-salbutamol sulphation in the human liver and duodenal mucosa: interindividual variability.

Pacifici GM, Giulianetti B, Quilici MC, Spisni R, Nervi M, Giuliani L, Gomeni R.

Xenobiotica. 1997 Mar;27(3):279-86.

PMID:
9141235
47.
48.

Interest and reliability of a polymerase chain reaction on bone-marrow samples in the diagnosis of visceral leishmaniasis in AIDS.

Piarroux R, Gambarelli F, Toga B, Dumon H, Fontes M, Dunan S, Quilici M.

AIDS. 1996 Apr;10(4):452-3. No abstract available.

PMID:
8728058
49.

Phylogenetic relationships between Old World Leishmania strains revealed by analysis of a repetitive DNA sequence.

Piarroux R, Fontes M, Perasso R, Gambarelli F, Joblet C, Dumon H, Quilici M.

Mol Biochem Parasitol. 1995 Jul;73(1-2):249-52. No abstract available.

PMID:
8577334
50.

Comparison of PCR with direct examination of bone marrow aspiration, myeloculture, and serology for diagnosis of visceral Leishmaniasis in immunocompromised patients.

Piarroux R, Gambarelli F, Dumon H, Fontes M, Dunan S, Mary C, Toga B, Quilici M.

J Clin Microbiol. 1994 Mar;32(3):746-9.

Supplemental Content

Loading ...
Support Center